FDA relents and will review Moderna's flu shot
The FDA will start a review of Moderna's flu jab mRNA-1010, after refusing to accept the filing last week, with a new "regulatory approach."
FDA starts review of BMS's 'celmod' for multiple myeloma
Bristol Myers Squibb could be months away from bringing the first 'celmod' to market, as the FDA starts a review of iberdomide for multiple myeloma.
Number of UK biotech companies rising, says report
A report has found that the number of life sciences companies domiciled in the UK has grown by nearly a quarter in the last few years.
Novartis' oral BTK drug moves the needle in CINDU
Novartis is set to expand the label for its oral BTK inhibitor Rhapsido, keeping the drug on course to become one of its biggest-ever brands.
NICE backs first disease-modifying drug for ARG1 deficiency
Immedica's Loargys is poised to become the first NHS therapy for ultra-rare genetic disorder ARG1 deficiency that can alter the course of the disease.
Sales & Marketing
Digital
Market Access
Oncology
Patients
R&D
Partner Content
The PM Society Launches Pharmony to Support More Effective P...
The Pharmaceutical Marketing Society (PM Society) today announces the launch of Pharmony
EVERSANA Names Monica Avram Executive Vice President and Chi...
As chief legal officer and a member of the Executive Leadership Team, Monica Avram leads EVERSANA's global Legal and Compliance function.
Emerging Trends in Personalised Medicine at PHARMAP 2026
The Pharmaceutical Manufacturing & Packaging Congress is an exclusive annual event that fosters networking and knowledge-sharing among professionals
Book your tickets and join the PM Society for the 40th PM Aw...
Tickets are on sale for the 40th anniversary of the PM Awards
The Pharmaceutical Manufacturing and Packaging Congress (PHA...
The Pharmaceutical Manufacturing and Packaging Congress (PHARMAP) 2026 unites professionals to discuss the most recent trends of industry in Amsterdam